Coexistence of functional angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans

Journal of Hypertension

Volumn 29, Issue 9, 2011, Pages 1743-1748

  Schinzari, Francesca ^a   Tesauro, Manfredi ^b   Rovella, Valentina ^b   Adamo, Angelo ^a   Mores, Nadia ^a   Cardillo, Carmine ^a  

^a Department of Internal Medicine ^*  (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

angiotensin; nitric oxide; receptors; vasoconstriction; vasodilation

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; ENZYME INHIBITION; FEMALE; FOREARM BLOOD FLOW; HEMODYNAMICS; HUMAN; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VASCULARIZATION; VASOCONSTRICTION; VASODILATATION;

EID: 80051947929     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328349ae0d     Document Type: Article

References (25)

1. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII: The angiotensin II receptors. Pharmacol Rev 2000; 52:415-472.
2. Lé vy BI. Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the reninangiotensin system. Circulation 2004; 109:8-13.
3. Tousoulis D, Koumallos N, Antoniades C, Antonopoulos AS, Bakogiannis C, Milliou A, et al. Genetic polymorphism on type 2 receptor of angiotensin II, modifies cardiovascular risk and systemic inflammation in hypertensive males. Am J Hypertens 2010; 23:237-242.
4. Batenburg WW, Garrelds IM, Bernasconi CC, Juillerat-Jeanneret L, van Kats JP, Saxena PR, Danser AH. Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation 2004; 109:2296-2301. (Pubitemid 38656868)
5. van de Wal RM, van der Harst P, Wagenaar LJ, Wassmann S, Morshuis WJ, Nickenig G, et al. Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease. J Cardiovasc Pharmacol 2007; 50:372-379. (Pubitemid 350303814)
6. MaassenVanDenBrink A, de Vries R, Saxena PR, Schalekamp MA, Danser AH. Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase. Cardiovasc Res 1999; 44:407-415. (Pubitemid 29474102)
7. Borland JA, Chester AH, Morrison KA, Yacoub MH. Alternative pathways of angiotensin II production in the human saphenous vein. Br J Pharmacol 1998; 125:423-428. (Pubitemid 28451477)
8. Garcia C, Kilcoyne CM, Cardillo C, Cannon RO III, Quyyumi AA, Panza JA. Evidence that endothelial dysfunction in patients with hypercholesterolemia is not due to increased extracellular nitric oxide breakdown by superoxide anions. Am J Cardiol 1995; 76:1157-1161.
9. Baan J Jr, Chang PC, Vermeij P, Pfaffendorf M, van Zwieten PA. Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers. Cardiovasc Res 1996; 32:973-979. (Pubitemid 26342663)
10. Cao Z, Dean R, Wu L, Casley D, Cooper ME. Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy. Hypertension 1999; 34:408-414. (Pubitemid 29426756)
11. van Esch JH, Schuijt MP, Sayed J, Choudhry Y, Walther T, Jan Danser AH. AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation. Br J Pharmacol 2006; 148:452-458. (Pubitemid 43882081)
12. Moltzer E, Verkuil AV, van Veghel R, Danser AH, van Esch JH. Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat: loss of angiotensin II type 2 receptor-mediated vasodilation. Hypertension 2010; 55:516-522.
13. Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, et al. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 1996; 98:418-425. (Pubitemid 26255741)
14. Hayashi K, Suzuki H, Saruta T. Segmental differences in angiotensin receptor subtypes in interlobular artery of hydronephrotic rat kidneys. Am J Physiol 1993; 265 (Pt 2):F881-F885.
15. Touyz RM, Endemann D, He G, Li JS, Schiffrin EL. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension 1999; 33:366-372. (Pubitemid 29065686)
16. Schuijt MP, Basdew M, van Veghel R, de Vries R, Saxena PR, Schoemaker RG, Danser AH. AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction. Am J Physiol Heart Circ Physiol 2001; 281:H2590-H2596.
17. Hannan RE, Davis EA, Widdop RE. Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide. Br J Pharmacol 2003; 140:987-995. (Pubitemid 37464083)
18. Baranov D, Armstead WM. Nitric oxide contributes to AT2 but not AT1 angiotensin II receptor-mediated vasodilatation of porcine pial arteries and arterioles. Eur J Pharmacol 2005; 525:112-116. (Pubitemid 41689030)
19. Stennett AK, Qiao X, Falone AE, Koledova VV, Khalil RA. Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats. Am J Physiol Heart Circ Physiol 2009; 296:H745-H755.
20. Bosnyak S, Welungoda IK, Hallberg A, Alterman M, Widdop RE, Jones ES. Stimulation of angiotensin AT2 receptors by the nonpeptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br J Pharmacol 2010; 159:709-716.
21. You D, Loufrani L, Baron C, Levy BI, Widdop RE, Henrion D. High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats. Circulation 2005; 111:1006-1011. (Pubitemid 40354518)
22. Pinaud F, Bocquet A, Dumont O, Retailleau K, Baufreton C, Andriantsitohaina R, et al. Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats. Hypertension 2007; 50:96-102. (Pubitemid 46986016)
23. Schuijt MP, de Vries R, Saxena PR, Schalekamp MA, Danser AH. Vasoconstriction is determined by interstitial rather than circulating angiotensin II. Br J Pharmacol 2002; 135:275-283. (Pubitemid 34102122)
24. Widdop RE, Jones ES, Hannan RE, Gaspari TA. Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol 2003; 140:809-824. (Pubitemid 37464062)
25. Savoia C, Touyz RM, Volpe M, Schiffrin EL. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension 2007; 49:341-346. (Pubitemid 46143011)